Clinical Trial Update: The Efficacy of Nitric Oxide in Stroke (ENOS) Trial [Phase 3]

View source ↗

Summary

Phase 3 ENOS trial evaluating glyceryl trinitrate (nitric oxide donor) for acute stroke; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Glyceryl Trinitrate (glyceryl trinitrate)

Snippet

Sponsor: University of Nottingham | Conditions: Stroke | Phase 3 | Status: UNKNOWN